GlaxoSmithKline Pharmaceuticals today reported standalone net profit of Rs 88.59 crore for the first quarter of the current fiscal.
It had posted a net profit of Rs 26.42 crore for April-June quarter of last fiscal, 2017-18, GlaxoSmithKline said in a filing to BSE.
The company's standalone total income was Rs 753.43 crore for the first quarter of 2018-19. It was Rs 620.84 crore for the year-ago period.
It said the figures for the quarter ended June 30, 2018-19 are not comparable with the corresponding quarter of last fiscal.
The board has approved and recommended a bonus issue of one equity share for every equity share held as on a record date to be determined, GlaxoSmithKline said.
The company's stock closed at Rs 3,150.90 BSE, up 13.91 per cent, on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app